Viridian Therapeutics

Viridian Therapeutics Employees

7 people indexed:

Jennifer Tousignant

Chief Legal Officer
Seth Harmon

Senior Vice President of Finance and Accounting

zkfyf05@wl2l11x70fzfkzk9146x.zl2 Sign up to see email

ly3kkfk@0zbff40869b7jq7w3f71.w4z Sign up to see email
Shan Wu

Chief Business Officer

7y7@g1yqkj1xf978fj0z8gk7.6gq Sign up to see email

f5q@zx2b83gl5ff7z6f2kfx8.y1z Sign up to see email
Steve Mahoney

President and Chief Executive Officer

818k8873@08747f01j2z5949474kl.zkz Sign up to see email

qb580866@g6gwzlqb246jfjlqfk09.399 Sign up to see email
Thomas Ciulla

Chief Medical Officer

17xyfw2@kf8f4082163g83z145j5.5gg Sign up to see email

5b5g946@95jxbfwx300jw522z280.k54 Sign up to see email
Tom Beetham

Chief Operating Officer
Tony Casciano

Chief Commercial Officer

2x34g1qf6@q54w78k7f9fjl09zg36j.4bj Sign up to see email

x3l51w1kj@glyq96z25xqk6j118fgb.4yy Sign up to see email

Viridian Therapeutics Company Information

Viridian Therapeutics is a biotechnology firm dedicated to creating best-in-class medicines for autoimmune and rare diseases. The company specializes in antibody discovery and engineering, utilizing this expertise to develop a robust pipeline of investigational therapeutic candidates targeting well-validated biological pathways. One of their key focus areas is the thyroid eye disease program, which aims to improve upon current standard-of-care treatments. Viridian Therapeutics is actively conducting global Phase 3 trials for this condition and is developing a portfolio of anti-IGF-1R monoclonal antibodies specifically for thyroid eye disease. Additionally, the company is advancing a preclinical pipeline of therapeutic antibody programs targeting various rare and autoimmune diseases. Viridian Therapeutics also offers a comprehensive benefits package to its employees, encompassing health, financial, and other benefits to support their well-being and professional growth.

Report inaccurate information